Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
Kaluza for Gallios Delivers Ease of Use, Analytical Power for Researchers
Saturday, May 10, 2014
Beckman Coulter offers new software package for data acquisition in cytometry, for use across cell analysis applications.
Dako Launches Two Ready-to-Use Antibodies for Cancer Diagnosis
Wednesday, May 07, 2014
Company announces addition of Anti-CK 8/18 and Anti-TdT antibodies for routine diagnostic use.
Flexible Forward Scatter Technology Enables Advances
Thursday, May 01, 2014
MoFlo® Astrios EQ from Beckman Coulter Life Sciences Delivers Simultaneous High-speed Cell Sorting and Sub-micron Particle Detection.
Molecular Devices Introduces Microplate Reader and Washer
Monday, April 28, 2014
The inexpensive and versatile EMax® Plus Microplate Reader and MultiWash™+ Microplate Washer are designed for labs just starting up or looking to extend capabilities with affordable, yet reliable instrumentation that utilizes the industry-standard SoftMax® Pro Microplate Data Acquisition and Analysis Software.
New Approach to Temperature Control in Cell Therapy Clinical Trial
Wednesday, April 23, 2014
CoolCell® cell freezing device and CoolBox™ ice-free cooling workstations chosen to support handling and processing of investigational cell therapy product in landmark clinical research trial.
New Monoclonal Antibodies to Mumps Virus
Friday, April 18, 2014
3 New monoclonal antibodies function in ELISA and IFA.
Molecular Devices to Attend Fourth Annual European Lab Automation (ELA) 2014
Wednesday, April 16, 2014
Molecular Devices® will be showcasing the next generation SpectraMax® MiniMax™ 300 imaging cytometer.
Hevylite® FDA Cleared to Help Monitor Patients with IgG and IgA Myeloma
Friday, April 11, 2014
Hevylite® measures the concentration of each immunoglobulin subtype.
Immunovaccine's DepoVax™ Technology Underpins New Experimental Therapy for Cancers
Wednesday, April 09, 2014
IMV vaccine adjuvant technology of choice for Dana-Farber's HPV-related cancer clinical trial.
Showing Results 61 - 70 of 393
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Iron Regulators Join War on Pathogens
Iron regulatory proteins (IRPs) play an important role in the body’s immune system.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,400+ scientific and medical posters
3,700+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!